Contracts Finder · Award
Human Albumin
A public procurement published by NHS England via Contracts Finder.
- £52.8m
- Award value
- £26.4m
- Tender value
- 5
- Suppliers
- 6
- Awards
- 2
- Notices
- Award
- Stage
Overview
NHS Framework Agreement for the supply of Human Albumin
Key details
- Buyer
- NHS England
- Source
- Contracts Finder
- Lifecycle stage
- Award
- Status
- complete
- CPV classification
- 33141540 — Albumin
- Currency
- GBP
- Total award value
- £52,800,000
- Tender value
- £26,400,000
- First published
- 12 Apr 2021
- Last updated
- 30 Apr 2021
Awards
6 awards recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| Bio Products Laboratory Ltd | 07343036 | 18 Mar 2021 | active | £26.4m |
| Bio Products Laboratory Ltd | 07343036 | 18 Mar 2021 | active | £26.4m |
| Biotest UK Limited | — | 18 Mar 2021 | active | £26.4m |
| CSL Behring UK Ltd | 01622483 | 18 Mar 2021 | active | £26.4m |
| Grifols UK Ltd. | 01456099 | 18 Mar 2021 | active | £26.4m |
| Octapharma Limited | 02372699 | 18 Mar 2021 | active | £26.4m |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
FAQs about this procurement
Who is the buyer for "Human Albumin"?
Human Albumin is a UK public-sector procurement published by NHS England via Contracts Finder.
Has "Human Albumin" been awarded?
Yes — 6 awards are recorded, with a reported total value of £52,800,000. The current lifecycle stage is "Award".
Which suppliers are involved in "Human Albumin"?
5 suppliers are linked: Bio Products Laboratory Ltd, Biotest UK Limited, CSL Behring UK Ltd, Grifols UK Ltd., Octapharma Limited.
What is "Human Albumin" worth?
The reported award value is £52,800,000.
When was "Human Albumin" published?
It was first published on 12 Apr 2021 and last updated on 30 Apr 2021, across 2 notices.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable